H/O: insulin therapy
Related entities
Findings (27)
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage
None
adverseA majority of patients with diabetes held misconceptions about insulin: 61.3% agreed or were unsure that insulin could damage their kidneys, 37.2% that it could cause blindness, and 55.4% that requiri
Effect: adverse; 61.3% agreed/unsure insulin damages kidneys; 37.2% agreed/unsure insulin causes blindness; 55.4% agreed/unsure insulin = final disease stage